Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALM
NCT04285346Phase 2Completed
- Sponsor
- Marinus Pharmaceuticals
- Start
- Apr 2020
- Primary completion
- Jun 2021
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of ganaxolone in tuberous sclerosis complex (TSC), sponsored by Marinus Pharmaceuticals. Started Apr 2020; status: completed.
02
Drugs
ganaxolone
03
Conditions
tuberous sclerosis complex (TSC)
Beyond the preview
Go deeper on NCT04285346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04285346.